Profile
Catherine Isted is currently the Chief Financial Officer at BenevolentAI SA since 2023.
Prior to this, she was the Chief Executive Officer & Executive Director at ReNeuron Group Plc from 2021 to 2023, Head-Corporate Development & Investor Relations at Oxford Biomedica Plc from 2019 to 2021, Sales Associate at Peel Hunt LLP from 2015 to 2019, and Sales Associate at Nomura Code Securities Ltd.
from 2009 to 2013.
Catherine Isted active positions
| Companies | Position | Start |
|---|---|---|
| BENEVOLENTAI | Director of Finance/CFO | 2023-09-10 |
Former positions of Catherine Isted
| Companies | Position | End |
|---|---|---|
| RENEURON GROUP PLC | Chief Executive Officer | 2023-01-02 |
| OXFORD BIOMEDICA PLC | Public Communications Contact | 2021-09-30 |
Peel Hunt LLP
 Peel Hunt LLP Investment Banks/BrokersFinance Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks. | Sales & Marketing | 2018-12-31 |
| Nomura Code Securities Ltd. | Analyst-Equity | 2009-07-16 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| OXFORD BIOMEDICA PLC | Health Technology |
| RENEURON GROUP PLC | Health Technology |
| BENEVOLENTAI | Health Technology |
| Private companies | 2 |
|---|---|
| Nomura Code Securities Ltd. | Finance |
Peel Hunt LLP
Peel Hunt LLP Investment Banks/BrokersFinance Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks. | Finance |
- Stock Market
- Insiders
- Catherine Isted
